Education
About Us
Working with TipRanks
Follow Us
Burning Rock Biotech Ltd. (BNR)
NASDAQ:BNR
BNR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.18 - $11.12
Previous CloseN/A
Volume1.44K
Average Volume (3M)61.73K
Market Cap
$90.93M
Enterprise Value-$14.33M
Total Cash (Recent Filing)$519.85M
Total Debt (Recent Filing)$52.32M
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Nov 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding9,034,111
10 Day Avg. Volume31,660
30 Day Avg. Volume61,735
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap-0.16
Enterprise Value/Revenue-0.03
Enterprise Value/Gross Profit-0.04
Enterprise Value/Ebitda0.05
Forecast
1Y Price Target
$6.00Price Target Upside-28.99% Downside
Rating ConsensusHold
Number of Analyst Covering0
Burning Rock Biotech News
BNR FAQ
What was Burning Rock Biotech Ltd.’s price range in the past 12 months?
Burning Rock Biotech Ltd. lowest stock price was $2.18 and its highest was $11.12 in the past 12 months.
What is Burning Rock Biotech Ltd.’s market cap?
Burning Rock Biotech Ltd.’s market cap is $90.93M.
When is Burning Rock Biotech Ltd.’s upcoming earnings report date?
Burning Rock Biotech Ltd.’s upcoming earnings report date is Nov 18, 2025 which is in 73 days.
How were Burning Rock Biotech Ltd.’s earnings last quarter?
Currently, no data Available
Is Burning Rock Biotech Ltd. overvalued?
According to Wall Street analysts Burning Rock Biotech Ltd.’s price is currently Overvalued.
Does Burning Rock Biotech Ltd. pay dividends?
Burning Rock Biotech Ltd. does not currently pay dividends.
What is Burning Rock Biotech Ltd.’s EPS estimate?
Burning Rock Biotech Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Burning Rock Biotech Ltd. have?
Burning Rock Biotech Ltd. has 9,034,111 shares outstanding.
What happened to Burning Rock Biotech Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Burning Rock Biotech Ltd.?
Currently, no hedge funds are holding shares in BNR
Burning Rock Biotech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$6.00 (-28.99% Downside)
$6.00 (-28.99% Downside)
Hedge Fund Trend
Decreased
By 1.7K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
77.89%
12-Months-Change
Fundamentals
Return on Equity
-37.15%
Trailing 12-Months
Asset Growth
-13.51%
Trailing 12-Months
Company Description
Burning Rock Biotech Ltd.
Burning Rock Biotech (BNR) is a leading biotechnology company focused on the development of innovative cancer diagnostics. Operating primarily in the healthcare and biotechnology sectors, the company specializes in next-generation sequencing (NGS) solutions that enable precision oncology. Burning Rock Biotech provides a comprehensive suite of products and services, including diagnostic tests for early cancer detection, treatment selection, and monitoring of disease progression, aimed at improving patient outcomes.
Technical Analysis
Ownership Overview
―
Insiders
0.34% Mutual Funds
14.50% Other Institutional Investors
85.17% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---